Back
  1. Home
  2. Profile of Marie Piette (ULiège)
Profil

Piette Marie

Service administratif de la Faculté (Médecine)

Département de pharmacie

See author's contact details
Main Referenced Co-authors
Evrard, Brigitte  (25)
Piel, Géraldine  (20)
Delattre, Luc  (18)
Castagne, Delphine  (13)
Barillaro, Valery (8)
Main Referenced Keywords
cyclodextrin (4); liposome (4); Ro 28-2653 (4); cholesterol (3); matrix metalloproteinase inhibitor (3);
Main Referenced Unit & Research Centers
Centre Interfacultaire de Recherche du Médicament - CIRM (5)
Main Referenced Disciplines
Pharmacy, pharmacology & toxicology (26)
Chemistry (4)
Biochemistry, biophysics & molecular biology (2)
Oncology (1)

Publications (total 29)

The most downloaded
251 downloads
Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2006). Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. European Journal of Pharmaceutical Sciences, 28 (3), 189-195. doi:10.1016/j.ejps.2006.01.011 https://hdl.handle.net/2268/11901

The most cited

94 citations (Scopus®)

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (07 April 2006). Betamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics. International Journal of Pharmaceutics, 312 (1-2), 75-82. doi:10.1016/j.ijpharm.2005.12.044 https://hdl.handle.net/2268/18659

Furst, T., Piette, M., Lechanteur, A., Evrard, B., & Piel, G. (2015). Mucoadhesive cellulosic derivative sponges as drug delivery system for vaginal application. European Journal of Pharmaceutics and Biopharmaceutics. doi:10.1016/j.ejpb.2015.01.019
Peer Reviewed verified by ORBi

Mehuys, E., Paemeleire, K., Van Hees, T., Christiaens, T., Van Bortel, L., Van Tongelen, I., Philippe, G., Prévôt, M.-L., Evrard, B., Piette, M., De Bolle, L., Remon, J., & Boussery, K. (2014). Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie [Paper presentation]. Prisma Symposium, Amersfoort, Netherlands.

Furst, T., Lechanteur, A., Evrard, B., Delvenne, P., Hubert, P., Piette, M., & Piel, G. (22 October 2012). Development of a topical formulation containing lipoplexes able to inhibit E6 and E7 genes for the treatment of cervix cancer caused by HPV16 and HPV18 [Poster presentation]. NanoFar 1st Autumn School, Angers, France.

Mehuys, E., Paemeleire, K., Van Hees, T., Van Bortel, L., Van Tongelen, I., Philippe, G., Prévôt, M.-L., Evrard, B., Piette, M., De Bolle, L., Remon, J., & Boussery, K. (September 2012). Zelfbehandeling van frequente hoofdpijn : een Belgische apotheekstudie [Paper presentation]. Second Belgian Pharmaceutical Care Symposium : Quality of care - Care for quality, Bruxelles, Belgium.

Mehuys, E., Paemeleire, K., Van Hees, T., Christiaens, T., Van Bortel, L., Van Tongelen, I., Philippe, G., Prévôt, M.-L., Evrard, B., Piette, M., De Bolle, L., Remon, J.-P., & Boussery, K. (June 2012). Automédication des céphalées fréquentes : étude dans les officines belges. Journal de Pharmacie de Belgique, 2, 4-10.
Peer Reviewed verified by ORBi

Jost, M., Frankenne, F., Maillard, C., Hubert, P., Herman, L., Delvenne, P., Piette, M., Coia, I., Evrard, B., Lecomte, F., Hubert, P., Englert, Y., Bossens, M., van Pachterbeke, C., GOFFIN, F., Doyen, J., Kridelka, F., Snoeck, R., & FOIDART, J.-M. (20 May 2011). From the Clinics to the Bench and back to the Clinics: design of a medical treatment for Cervical Intraepithelial Neoplasia (CIN) [Paper presentation]. GIGA-Cancer Day, Liège, Belgium.

Philippe, G., Angenot, L., Evrard, B., Giet, D., Piette, M., Prévôt, M.-L., & BOURGUIGNON, J.-P. (18 September 2010). L'ECOS ou 'comment les pharmaciens d'officine évaluent l'aptitude des étudiants à prodiguer des soins pharmaceutiques de qualité' [Paper presentation]. First Pharmaceutical Care Symposium, Bruxelles, Belgium.

Coia, I., Evrard, B., & Piette, M. (01 April 2009). Preparations and characterisations of semi-solid formulations containing a hydrophilic drug for vaginal administration [Poster presentation]. Biomedica, Liège, Belgium.

Castagne, D., Blacher, S., Alvarez Gonzalez, M.-L., Berndt, S., Piette, M., Evrard, B., Nusgens, B., Noël, A., & Piel, G. (May 2008). Effect of b-cyclodextrin and its methylated derivatives on the ex-vivo rat aortic ring angiogenesis assay [Poster presentation]. XIIth BELACT Meeting, Namur, Belgium.

Volvert, M.-L., Seyen, S., Piette, M., Evrard, B., Gangolf, M., Plumier, J.-C., & Bettendorff, L. (2008). Benfotiamine, a synthetic S-acyl thiamine derivative, has different mechanisms of action and a different pharmacological profile than lipid-soluble thiamine disulfide derivatives. BMC Pharmacology, 8, 10. doi:10.1186/1471-2210-8-10
Peer Reviewed verified by ORBi

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (29 June 2007). Study of the relationship between lipid binding properties of cyclodextrins and their effect on the integrity of liposomes. International Journal of Pharmaceutics, 338 (1-2), 35-42. doi:10.1016/j.ijpharm.2007.01.015
Peer Reviewed verified by ORBi

Piette, M., Castagne, D., Delattre, L., & Piel, G. (April 2007). Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 101-103. doi:10.1007/s10847-006-9214-y
Peer reviewed

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (April 2007). Study of the interaction between cyclodextrins and liposome membranes: effect on the permeability of liposomes. Journal of Inclusion Phenomena and Macrocyclic Chemistry, 57 (1-4), 309-311. doi:10.1007/s10847-006-9178-y
Peer reviewed

Evrard, B., Bertholet, P., Guéders, M., Piette, M., Piel, G., Cataldo, D., & Delattre, L. (2007). Contribution of cyclodextrins in the developement of different pharmaceutical formulations of a nex matrix metalloproteinase inhibitor. Journal of Inclusion Phenomena and Molecular Recognition in Chemistry, 57 (1-4), 303-308. doi:10.1007/s10847-006-9177-z
Peer Reviewed verified by ORBi

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2006). Pharmacokinetic study of a new synthetic MMP inhibitor (Ro 28-2653) after IV and oral administration of cyclodextrin solutions. European Journal of Pharmaceutical Sciences, 28 (3), 189-195. doi:10.1016/j.ejps.2006.01.011
Peer Reviewed verified by ORBi

Piette, M., Castagne, D., Delattre, L., & Piel, G. (May 2006). Preparation and evaluation of liposomes encapsulating synthetic MMP inhibitor (Ro 28-2653) - cyclodextrin complexes [Poster presentation]. 13th International Cyclodextrin Symposium, Turin, Italy.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (07 April 2006). Betamethasone-in-cyclodextrin-in-liposome: The effect of cyclodextrins on encapsulation efficiency and release kinetics. International Journal of Pharmaceutics, 312 (1-2), 75-82. doi:10.1016/j.ijpharm.2005.12.044
Peer Reviewed verified by ORBi

Stassen, T., Piette, M., Kinget, R., & Delattre, L. (2006). Etude des performances d'appareils de melange Unguator pour la preparation magistrale a usage dermatologique. Journal de Pharmacie de Belgique, 61 (1), 1-10.
Peer Reviewed verified by ORBi

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (2006). Study of the interaction between cyclodextrins and liposomes membranes: effect on the permeability of liposomes [Paper presentation]. XIII th International Cyclodextrin Symposium, Torino, Italy.

Piel, G., Piette, M., Barillaro, V., Castagne, D., Evrard, B., & Delattre, L. (November 2005). Effect of cyclodextrins on the membrane permeability of liposomes [Poster presentation]. 2nd EUFEPS conference on optimising drug delivery and formulation, Versailles, France.

Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (September 2005). Encapsulation of betamethasone-cyclodextrin inclusion complexes in liposmes: effect of cyclodextrins on the encapsulation efficinecy and the kinetic release of betamethasone [Poster presentation]. 15th International Symposium on Microencapsulation, Parma, Italy.

Bertholet, P., Jaspart, S., Bodson, C., Piette, M., Piel, G., Delattre, L., & Evrard, B. (June 2005). The effect of cyclodextrins on the aqueous solubility of a new MMP inhihbitor: phase solubility, 1H-NMR spectroscopy and molecular modelling studies, preparation and stability study of nebulizable solutions [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France.

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (June 2005). Pharmacokinetic study of a new syntheyic MMP inhibitor (Ro 28-2653) after IV and oral administration of solutions containing hydroxypropyl-b-cyclodextrin [Poster presentation]. 1st Pharmaceutical Sciences Fair and Exhibition (PharmSciFair), Nice, France.

Chiap, P., Piette, M., Evrard, B., Frankenne, F., Christiaens, B., Piel, G., Cataldo, D., Foidart, J.-M., Delattre, L., Crommen, J., & Hubert, P. (05 March 2005). Automated method for the determination of a new matrix metalloproteinase inhibitor in ovine plasma and serum by coupling of restricted access material for on-line sample clean-up to liquid chromatography. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 817 (1), 109-117. doi:10.1016/j.jchromb.2004.08.042
Peer Reviewed verified by ORBi

Piel, G., Piette, M., Castagne, D., Barillaro, V., Evrard, B., & Delattre, L. (March 2005). Influence des cyclodextrines sur la vitesse de libération de la bétamethasone encapsulée sous forme de complexe dans des liposomes [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France.

Piette, M., Evrard, B., Frankenne, F., Chiap, P., Bertholet, P., Castagne, D., Foidart, J.-M., Delattre, L., & Piel, G. (March 2005). Etude pharmacocinétique d'un nouvel inhibiteur des MMPs (I-col 51) après administration orale et intraveineuse de soultions à base d'hydroxypropyl-b-cyclodextrine [Paper presentation]. 8èmes Journées du Club français des Cyclodextrines, Nancy, France.

Piette, M. (2004). Etude de l'interaction d'un inhibiteur des métalloprotéases matricielles - Ro 28-2653 - avec les cyclodextrines: développements galénique et analytique et étude pharmacocinétique chez l'animal [Specialised master, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/56841

Piel, G., Moutard, S., Perly, B., Henry de Hassonville, S., Bertholet, P., Barillaro, V., Piette, M., Delattre, L., & Evrard, B. (2004). Comparison of two methods currently used to determine the interaction between cyclodextrins and drugs: phase solubility diagrams and NMR spectroscopy. Journal of Drug Delivery Science and Technology, 14 (1, JAN-FEB), 87-91. doi:10.1016/s1773-2247(04)50010-2
Peer reviewed

Bertolla, C., Piette, M., Evrard, B., Delattre, L., Piel, G., Frédérick, R., & Masereel, B. (May 2003). Synthèse de b-cyclodextrines modifiées [Poster presentation]. 17th Journées Franco-belges de Pharmacochimie, Bruxelles, Belgium.

Contact ORBi